We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Yellow fever: is Asia bound to encounter the virus?

    Baijayantimala Mishra

    *Author for correspondence: Tel.: +91 943 888 4121;

    E-mail Address: bmishramicro@gmail.com

    Department of Microbiology, All India Institute of Medical Sciences, Bhubaneswar, 751019, Odisha, India

    ,
    Sutapa Rath

    Department of Microbiology, All India Institute of Medical Sciences, Bhubaneswar, 751019, Odisha, India

    ,
    Monalisa Mohanty

    Department of Microbiology, All India Institute of Medical Sciences, Bhubaneswar, 751019, Odisha, India

    &
    Prabhudutta Mamidi

    Department of Microbiology, All India Institute of Medical Sciences, Bhubaneswar, 751019, Odisha, India

    Published Online:https://doi.org/10.2217/fvl-2023-0128
    Free first page

    Papers of special note have been highlighted as: • of interest; •• of considerable interest

    References

    • 1. Kallas EG, Wilder-Smith A. Managing severe yellow fever in the intensive care: lessons learnt from Brazil. J. Travel Med. 26(5), taz043 (2019). • Paper that describes the clinical spectrums of yellow fever.
    • 2. Ho YL, Joelsons D, Leite GFC et al. Severe yellow fever in Brazil: clinical characteristics and management. J. Travel Med. 26(5), taz040 (2019). • A study that described the clinical management of severe yellow fever infection.
    • 3. Cunha MDP, Duarte-Neto AN, Pour SZ et al. Phylogeographic patterns of the yellow fever virus around the metropolitan region of São Paulo, Brazil, 2016–2019. PLOS Negl. Trop. Dis. 16(9), e0010705 (2022).
    • 4. Rodríguez-Morales AJ, Bonilla-Aldana DK, Suárez JA et al. Yellow fever reemergence in Venezuela - Implications for international travellers and Latin American countries during the COVID-19 pandemic. Travel Med. Infect. Dis. 44, 102192 (2021). • Article on importance of immunization coverage and optimization of surveillance system for populations at risk of yellow fever.
    • 5. Gardner CL, Ryman KD. Yellow fever: a reemerging threat. Clin. Lab. Med. 30(1), 237–260 (2010).
    • 6. Gubler DJ. Pandemic yellow fever: a potential threat to global health via travellers. J. Travel Med. 25(1), (2018). •• One of the earliest paper emphasising on the pandemic potential of yellow fever.
    • 7. Song R, Guan S, Lee SS et al. Late or Lack of Vaccination Linked to Importation of Yellow Fever from Angola to China. Emerg. Infect. Dis. 24(7), 1383–1386 (2018).
    • 8. UNICEF. In Angola keeping the yellow fever cases at zero. https://www.unicef.org/stories/angola-keeping-yellow-fever-cases-zero • Describes and updates the current situation of yellow fever in Angola.
    • 9. Kuno G. The Absence of Yellow Fever in Asia: History, Hypotheses, Vector Dispersal, Possibility of YF in Asia, and Other Enigmas. Viruses. 12(12), 1349 (2020).
    • 10. Manson P. The relation of the Panama Canal to the introduction of yellow fever into Asia. Tran. Epidemiol. Soc. Lond. 22, 60–100 (1903). • One of the earliest article describing the possible mode of transmission of yellow fever from endemic areas to Asia.
    • 11. Baker RE, Mahmud AS, Miller IF et al. Infectious disease in an era of global change. Nat. Rev. Microbiol. 20(4), 193–205 (2022). •• Review on the effect of climate changes and other key determinants on emerging and re-emerging infectious diseases.
    • 12. Brent SE, Watts A, Cetron M et al. International travel between global urban centres vulnerable to yellow fever transmission. Bull World Health Organ. 96(5), 343–354B (2018).
    • 13. Blake LE, Garcia-Blanco MA. Human genetic variation and yellow fever mortality during 19th century U.S. epidemics. mBio. 5(3), e01253–14 (2014).
    • 14. Saron WAA, Rathore APS, Ting L et al. Flavivirus serocomplex cross-reactive immunity is protective by activating heterologous memory CD4 T cells. Sci Adv. 4(7), eaar4297 (2018).
    • 15. Rosser JI, Nielsen-Saines K, Saad E, Fuller T. Reemergence of yellow fever virus in southeastern Brazil, 2017–2018: what sparked the spread? PLOS Negl. Trop. Dis. 16(2), e0010133 (2022).
    • 16. Calvez E, O'Connor O, Pol M et al. Differential transmission of Asian and African Zika virus lineages by Aedes aegypti from New Caledonia. Emerg. Microbes Infect. 7(1), 15 (2018).
    • 17. Ahebwa A, Hii J, Neoh KB, Chareonviriyaphap T. Aedes aegypti and Aedes albopictus (Diptera: culicidae) ecology, biology, behaviour, and implications on arbovirus transmission in Thailand: Review. One Health 30(16), 100555 (2023). •• Review on factors affecting the competency of Aedes aegypti and Aedes albopictus mosquito in different disease transmission.
    • 18. Gubler DJ. Potential yellow fever epidemics in unexposed populations. Bull World Health Organ. 96(5), 299 (2018).